In accordance with the Ministry of Food and Drug Safety's change order for "clarithromycin single agent (oral: tablet)" approval (report acceptance) (Permission Review and Coordination Division No. 4309, effective date 2012.11.9), the dosage and precautions for use of Pyrosin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.